薬物乱用治療薬の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9103563）

◆英語タイトル：Global Substance Abuse Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9103563
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：121
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、薬物乱用治療薬の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院＆クリニック、住宅（病院以外）等に区分しました。薬物乱用治療薬の世界市場概観、企業動向、企業別薬物乱用治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・薬物乱用治療薬の市場概観
・薬物乱用治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・薬物乱用治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・薬物乱用治療薬の世界市場規模
・薬物乱用治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・薬物乱用治療薬のアメリカ市場規模推移
・薬物乱用治療薬のカナダ市場規模推移
・薬物乱用治療薬のメキシコ市場規模推移
・薬物乱用治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・薬物乱用治療薬のドイツ市場規模推移
・薬物乱用治療薬のイギリス市場規模推移
・薬物乱用治療薬のロシア市場規模推移
・薬物乱用治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・薬物乱用治療薬の日本市場規模推移
・薬物乱用治療薬の中国市場規模推移
・薬物乱用治療薬の韓国市場規模推移
・薬物乱用治療薬のインド市場規模推移
・薬物乱用治療薬の東南アジア市場規模推移
・薬物乱用治療薬の南米市場分析（ブラジル、アルゼンチン等）
・薬物乱用治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・薬物乱用治療薬の種類別分析/販売量、売上、市場シェア（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症）
・薬物乱用治療薬の用途別分析/市場規模（病院＆クリニック、住宅（病院以外））
・薬物乱用治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・薬物乱用治療薬の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Scope of the Report:
The global Substance Abuse Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Substance Abuse Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Substance Abuse Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Substance Abuse Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy’s Laboratories
Teva Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence

Market Segment by Applications, can be divided into
Hospital & Clinics
Residential (non-hospital)

【レポートの目次】

Table of Contents

1 Substance Abuse Therapeutics Market Overview
1.1 Product Overview and Scope of Substance Abuse Therapeutics
1.2 Classification of Substance Abuse Therapeutics by Types
1.2.1 Global Substance Abuse Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Substance Abuse Therapeutics Revenue Market Share by Types in 2018
1.2.3 Opioid Addiction
1.2.4 Tobacco/Nicotine Addiction
1.2.5 Alcohol Dependence
1.3 Global Substance Abuse Therapeutics Market by Application
1.3.1 Global Substance Abuse Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Global Substance Abuse Therapeutics Market by Regions
1.4.1 Global Substance Abuse Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Substance Abuse Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Substance Abuse Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Substance Abuse Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Substance Abuse Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Substance Abuse Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Substance Abuse Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 Indivior
2.1.1 Business Overview
2.1.2 Substance Abuse Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Indivior Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Substance Abuse Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Alkermes
2.3.1 Business Overview
2.3.2 Substance Abuse Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alkermes Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Substance Abuse Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Substance Abuse Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Substance Abuse Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Glenmark
2.7.1 Business Overview
2.7.2 Substance Abuse Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Glenmark Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Dr. Reddy’s Laboratories
2.8.1 Business Overview
2.8.2 Substance Abuse Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dr. Reddy’s Laboratories Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Substance Abuse Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Substance Abuse Therapeutics Market Competition, by Players
3.1 Global Substance Abuse Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Substance Abuse Therapeutics Players Market Share
3.2.2 Top 10 Substance Abuse Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Substance Abuse Therapeutics Market Size by Regions
4.1 Global Substance Abuse Therapeutics Revenue and Market Share by Regions
4.2 North America Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Substance Abuse Therapeutics Revenue by Countries
5.1 North America Substance Abuse Therapeutics Revenue by Countries (2014-2019)
5.2 USA Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Substance Abuse Therapeutics Revenue by Countries
6.1 Europe Substance Abuse Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Substance Abuse Therapeutics Revenue by Countries
7.1 Asia-Pacific Substance Abuse Therapeutics Revenue by Countries (2014-2019)
7.2 China Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Substance Abuse Therapeutics Revenue by Countries
8.1 South America Substance Abuse Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Substance Abuse Therapeutics by Countries
9.1 Middle East and Africa Substance Abuse Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Substance Abuse Therapeutics Market Segment by Type
10.1 Global Substance Abuse Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Substance Abuse Therapeutics Market Forecast by Type (2019-2024)
10.3 Opioid Addiction Revenue Growth Rate (2014-2024)
10.4 Tobacco/Nicotine Addiction Revenue Growth Rate (2014-2024)
10.5 Alcohol Dependence Revenue Growth Rate (2014-2024)
11 Global Substance Abuse Therapeutics Market Segment by Application
11.1 Global Substance Abuse Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Substance Abuse Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital & Clinics Revenue Growth (2014-2019)
11.4 Residential (non-hospital) Revenue Growth (2014-2019)
12 Global Substance Abuse Therapeutics Market Size Forecast (2019-2024)
12.1 Global Substance Abuse Therapeutics Market Size Forecast (2019-2024)
12.2 Global Substance Abuse Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Substance Abuse Therapeutics Picture
Table Product Specifications of Substance Abuse Therapeutics
Table Global Substance Abuse Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Substance Abuse Therapeutics Revenue Market Share by Types in 2018
Figure Opioid Addiction Picture
Figure Tobacco/Nicotine Addiction Picture
Figure Alcohol Dependence Picture
Table Global Substance Abuse Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Substance Abuse Therapeutics Revenue Market Share by Applications in 2018
Figure Hospital & Clinics Picture
Figure Residential (non-hospital) Picture
Table Global Market Substance Abuse Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Indivior Basic Information, Manufacturing Base and Competitors
Table Indivior Substance Abuse Therapeutics Type and Applications
Table Indivior Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Substance Abuse Therapeutics Type and Applications
Table Pfizer Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Alkermes Basic Information, Manufacturing Base and Competitors
Table Alkermes Substance Abuse Therapeutics Type and Applications
Table Alkermes Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Substance Abuse Therapeutics Type and Applications
Table Novartis Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Substance Abuse Therapeutics Type and Applications
Table Mylan Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Substance Abuse Therapeutics Type and Applications
Table Cipla Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Basic Information, Manufacturing Base and Competitors
Table Glenmark Substance Abuse Therapeutics Type and Applications
Table Glenmark Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Substance Abuse Therapeutics Type and Applications
Table Dr. Reddy's Laboratories Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Substance Abuse Therapeutics Type and Applications
Table Teva Pharmaceutical Substance Abuse Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Substance Abuse Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Substance Abuse Therapeutics Revenue Share by Players (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Share by Players in 2017
Figure Global Substance Abuse Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Substance Abuse Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Substance Abuse Therapeutics Revenue Market Share in 2018
Figure Global Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Substance Abuse Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Substance Abuse Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Market Share by Regions in 2018
Figure North America Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Substance Abuse Therapeutics Revenue by Countries (2014-2019)
Table North America Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Substance Abuse Therapeutics Revenue Market Share by Countries in 2018
Figure USA Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Substance Abuse Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Substance Abuse Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Substance Abuse Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Substance Abuse Therapeutics Revenue Market Share by Countries in 2018
Figure China Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Substance Abuse Therapeutics Revenue by Countries (2014-2019)
Table South America Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Substance Abuse Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Substance Abuse Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Substance Abuse Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Substance Abuse Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Substance Abuse Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Substance Abuse Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Substance Abuse Therapeutics Revenue Share by Type (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Share by Type (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Share by Type in 2019
Table Global Substance Abuse Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Substance Abuse Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Opioid Addiction Revenue Growth Rate (2014-2019)
Figure Global Tobacco/Nicotine Addiction Revenue Growth Rate (2014-2019)
Figure Global Alcohol Dependence Revenue Growth Rate (2014-2019)
Table Global Substance Abuse Therapeutics Revenue by Application (2014-2019)
Table Global Substance Abuse Therapeutics Revenue Share by Application (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Share by Application (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue Share by Application in 2019
Table Global Substance Abuse Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Substance Abuse Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Hospital & Clinics Revenue Growth Rate (2014-2019)
Figure Global Residential (non-hospital) Revenue Growth Rate (2014-2019)
Figure Global Substance Abuse Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Substance Abuse Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Substance Abuse Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Substance Abuse Therapeutics Revenue Market Forecast (2019-2024)

【掲載企業】

Indivior、Pfizer、Alkermes、Novartis、Mylan、Cipla、Glenmark、Dr. Reddy's Laboratories、Teva Pharmaceutical、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 薬物乱用治療薬の世界市場2019(Global Substance Abuse Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp